Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study

BackgroundKnowledge of the prevalence of morbidity secondary to stroke is important for health care professionals, health care commissioners, third sector organizations, and stroke survivors to understand the likely progress of poststroke sequelae and to aid in commissioning...

Full description

Bibliographic Details
Main Authors: Smith, Alexander, Bains, Natalie, Copeland, Lauren, Pennington, Anna, Carter, Ben, Hewitt, Jonathan
Format: Article
Language:English
Published: JMIR Publications 2020-06-01
Series:JMIR Research Protocols
Online Access:https://www.researchprotocols.org/2020/6/e15851
id doaj-f3ef6c3dc93745a4ac9ae3b47c4465b7
record_format Article
spelling doaj-f3ef6c3dc93745a4ac9ae3b47c4465b72021-05-03T02:53:40ZengJMIR PublicationsJMIR Research Protocols1929-07482020-06-0196e1585110.2196/15851Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort StudySmith, AlexanderBains, NatalieCopeland, LaurenPennington, AnnaCarter, BenHewitt, Jonathan BackgroundKnowledge of the prevalence of morbidity secondary to stroke is important for health care professionals, health care commissioners, third sector organizations, and stroke survivors to understand the likely progress of poststroke sequelae and to aid in commissioning decisions, planning care, and adjusting to life after stroke. ObjectiveThe primary aim of the Morbidity PRevalence Estimate In StrokE (MORe PREcISE) study is to determine the prevalence of morbidity secondary to a stroke, predictors of morbidity, and trends in quality of life and functional status using patient-reported outcomes, cognitive and functional assessments. MethodsA total of 500 participants will be recruited across Wales and England within 14 days following an admission to a stroke unit for either an ischemic or hemorrhagic stroke as part of a multicenter cohort study. Participants are assessed at baseline ≤14 days poststroke and subsequently at 90 (± 14) days and 180 (± 14) days poststroke. At each time point, data will be collected relating to the following domains: participant demographics, routine clinical, patient reported, cognitive status, emotional well-being, and functional ability. ResultsRecruitment commenced in October 2018 with 20 sites opened as of September 2019 and was closed on October 31, 2019. ConclusionsThe primary outcome is the prevalence of morbidity at 6 months secondary to a stroke. Further analysis will consider temporal changes in the health-related domains to describe trends among baseline, 3-, and 6-month time points. Trial RegistrationClinicalTrials.gov NCT03605381; https://clinicaltrials.gov/ct2/show/NCT03605381 International Registered Report Identifier (IRRID)DERR1-10.2196/15851https://www.researchprotocols.org/2020/6/e15851
collection DOAJ
language English
format Article
sources DOAJ
author Smith, Alexander
Bains, Natalie
Copeland, Lauren
Pennington, Anna
Carter, Ben
Hewitt, Jonathan
spellingShingle Smith, Alexander
Bains, Natalie
Copeland, Lauren
Pennington, Anna
Carter, Ben
Hewitt, Jonathan
Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study
JMIR Research Protocols
author_facet Smith, Alexander
Bains, Natalie
Copeland, Lauren
Pennington, Anna
Carter, Ben
Hewitt, Jonathan
author_sort Smith, Alexander
title Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study
title_short Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study
title_full Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study
title_fullStr Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study
title_full_unstemmed Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study
title_sort morbidity prevalence estimate at 6 months following a stroke: protocol for a cohort study
publisher JMIR Publications
series JMIR Research Protocols
issn 1929-0748
publishDate 2020-06-01
description BackgroundKnowledge of the prevalence of morbidity secondary to stroke is important for health care professionals, health care commissioners, third sector organizations, and stroke survivors to understand the likely progress of poststroke sequelae and to aid in commissioning decisions, planning care, and adjusting to life after stroke. ObjectiveThe primary aim of the Morbidity PRevalence Estimate In StrokE (MORe PREcISE) study is to determine the prevalence of morbidity secondary to a stroke, predictors of morbidity, and trends in quality of life and functional status using patient-reported outcomes, cognitive and functional assessments. MethodsA total of 500 participants will be recruited across Wales and England within 14 days following an admission to a stroke unit for either an ischemic or hemorrhagic stroke as part of a multicenter cohort study. Participants are assessed at baseline ≤14 days poststroke and subsequently at 90 (± 14) days and 180 (± 14) days poststroke. At each time point, data will be collected relating to the following domains: participant demographics, routine clinical, patient reported, cognitive status, emotional well-being, and functional ability. ResultsRecruitment commenced in October 2018 with 20 sites opened as of September 2019 and was closed on October 31, 2019. ConclusionsThe primary outcome is the prevalence of morbidity at 6 months secondary to a stroke. Further analysis will consider temporal changes in the health-related domains to describe trends among baseline, 3-, and 6-month time points. Trial RegistrationClinicalTrials.gov NCT03605381; https://clinicaltrials.gov/ct2/show/NCT03605381 International Registered Report Identifier (IRRID)DERR1-10.2196/15851
url https://www.researchprotocols.org/2020/6/e15851
work_keys_str_mv AT smithalexander morbidityprevalenceestimateat6monthsfollowingastrokeprotocolforacohortstudy
AT bainsnatalie morbidityprevalenceestimateat6monthsfollowingastrokeprotocolforacohortstudy
AT copelandlauren morbidityprevalenceestimateat6monthsfollowingastrokeprotocolforacohortstudy
AT penningtonanna morbidityprevalenceestimateat6monthsfollowingastrokeprotocolforacohortstudy
AT carterben morbidityprevalenceestimateat6monthsfollowingastrokeprotocolforacohortstudy
AT hewittjonathan morbidityprevalenceestimateat6monthsfollowingastrokeprotocolforacohortstudy
_version_ 1721485043842416640